TotalMarketCap

BeOne Medicines

ONCNasdaq Cayman IslandsHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$44.042 B

$387.35 +2.53%

Close of 6 Nov 2026

As of 6 Nov 2026, BeOne Medicines (ONC) has a market capitalization of $44.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$5.34B

#634 by revenue

Earnings

$286.9M

#852 by earnings

Shares outstanding

1,484,939,031

Latest filing cover page

P/E ratio

153.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #15Takeda PharmaceuticalTAK$67.1B
  2. #16Teva Pharmaceutical IndustriesTEVA$48.7B
  3. #17BeOne MedicinesONC$44.0B
  4. #18Royalty PharmaRPRX$38.9B
  5. #19ZoetisZTS$33.9B

What if BeOne Medicines were worth as much as…

Open the what-if tool →

Gold $28.2T

$248,341.32

Per share 641× higher

Bitcoin $1.53T

$13,437.32

Per share 34.7× higher

Apple $5.02T

$44,113.45

Per share 114× higher

Or at a round number

$100.0B$200.0B$500.0B$1.00T

Where these numbers come from

Share counts and financials for BeOne Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.